2. Engagement within the new system
Paul McManus
Lead pharmacist - specialised services
South Yorkshire and Bassetlaw Area Team
ABPI Regional event June 2013
4. Opportunities for engagement
Product specific
National
• research
• pipeline
• commissioning
• value
• price
• placement
4
Local
• implementation
• price
• priorities
• problems
5. Medicines optimisation
Medicines still most common therapeutic
intervention and biggest cost after staff,
but, for example:
• 30 to 50% not taken as intended
• Patients have insufficient supporting
information
• UK Literature suggests 5 to 8% of hospital
admissions due to preventable adverse
effects of medicines
• Medication errors across all sectors and age
groups at unacceptable levels
• Medicines wastage in primary care: £300M pa
with £150M pa avoidable
• Relatively little effort towards understanding
clinical effectiveness of medicines in real
practice
• The threat of antimicrobial resistance
6. National Reporting and Learning System for England and Wales
Types of incidents 2005-10
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
7. NRLS in England and Wales
medication incident reports 2005 - 10
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
8. NRLS – who is reporting incidents?
8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
9. NRLS – Critical medicines
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
NRLS – Critical medicines
10. NRLS – Error category
Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
12. A strategy might include…
• Patient engagement
• Collaborative working across health economies
• Improving outcomes
• Value for money
• Partnership with industry
• Medicines pathway
• Safety and assurance
12
Information and technology
13. What can we do?
• Be an active commissioner
• Ensure contact at right level and make meetings
productive for all
• Look for ways to best use skills and resources
available
• Think beyond individual products
• Start talking 13
